ID   HLN-ATL-O
AC   CVCL_VN75
SY   HLN-ATL-0; LN-ATL-O
DR   Wikidata; Q94212296
RX   PubMed=2140233;
RX   PubMed=15871724;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VN76 ! HPB-ATL-O
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 10
//
RX   PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x;
RA   Nakano A., Harada T., Morikawa S., Kato Y.;
RT   "Expression of leukocyte common antigen (CD45) on various human
RT   leukemia/lymphoma cell lines.";
RL   Acta Pathol. Jpn. 40:107-115(1990).
//
RX   PubMed=15871724; DOI=10.1111/j.1440-1827.2005.01823.x;
RA   Nagasaki M., Zhang J., Morikawa S., Harada T., Nabika T., Tanaka Y.;
RT   "Human leukocyte antigen-class II-negative long-term cultured human
RT   T-cell leukemia virus type-I-infected T-cell lines with progressed
RT   cytological properties significantly induce superantigen-dependent
RT   normal T-cell proliferation.";
RL   Pathol. Int. 55:264-272(2005).
//